BELIXOS Trademark

Trademark Overview


On Wednesday, May 27, 2009, a trademark application was filed for BELIXOS with the United States Patent and Trademark Office. The USPTO has given the BELIXOS trademark a serial number of 79070762. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, February 26, 2021. This trademark is owned by Biofrontera Pharma GmbH. The BELIXOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of dermatological diseases and skin disorders; medicines for human purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; medicines for veterinary purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for medical purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for veterinary purposes, namely, medicines for the treatment of dermatological diseases and skin disorders; topical ointment and gels for the medical and therapeutic treatment of dermatological diseases and skin disorders; [ * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemia, in particular not for pharmaceutical preparations on the basis of mistleto...
belixos

General Information


Serial Number79070762
Word MarkBELIXOS
Filing DateWednesday, May 27, 2009
Status709 - CANCELLED - SECTION 71
Status DateFriday, February 26, 2021
Registration Number3771836
Registration DateTuesday, April 6, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 19, 2010

Trademark Statements


Certificate of Correction for RegistrationThe following "all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemia, in particular not for pharmaceutical preparations on the basis of mistletoe for the treatment of pre-cancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plamacytoma, for the stimulation of the bone marrow function and nutritional or dietary supplements" should be inserted at end of the class.
Certificate of Correction for RegistrationLine 15 through 22, "all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemia, in particular not for pharmaceutical preparations on the basis of mistletoe for the treatment of pre-cancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plamacytoma, for the stimulation of the bone marrow function and nutritional or dietary supplements" should be deleted, and "all aforementioned goods not for the treatment of cancer and leukemia and the treatment of side-effects occurring during the treatment of cancer and leukemia, particularly pharmaceutical preparations on the basis of mistletoes for the treatment of precancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plasmacytoms, for stimulating the bone marrow functions and as nutritional supplements" should be inserted.
Goods and ServicesPharmaceutical preparations for the treatment and prevention of dermatological diseases and skin disorders; medicines for human purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; medicines for veterinary purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for medical purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for veterinary purposes, namely, medicines for the treatment of dermatological diseases and skin disorders; topical ointment and gels for the medical and therapeutic treatment of dermatological diseases and skin disorders; [ * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemia, in particular not for pharmaceutical preparations on the basis of mistletoe for the treatment of pre-cancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plamacytoma, for the stimulation of the bone marrow function and nutritional or dietary supplements * ] * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of side-effects occurring during the treatment of cancer and leukemia, particularly pharmaceutical preparations on the basis of mistletoes for the treatment of precancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plasmacytoms, for stimulating the bone marrow functions and as nutritional supplements *

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiofrontera Pharma GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
Address51377 Leverkusen
DE

Party NameBiofrontera Pharma GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE

Party NameBiofrontera Pharma GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events


Event DateEvent Description
Saturday, January 15, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Sunday, December 19, 2021TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, December 18, 2021INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Thursday, June 13, 2019INTERNATIONAL REGISTRATION RENEWED
Saturday, April 6, 2019COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Friday, May 12, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 12, 2017PARTIAL INVALIDATION PROCESSED BY THE IB
Thursday, September 8, 2016PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, September 8, 2016INVALIDATION PROCESSED
Thursday, September 8, 2016PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 8, 2016NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, January 8, 2016REGISTERED-SEC.71 ACCEPTED
Friday, January 8, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, November 28, 2015TEAS SECTION 71 RECEIVED
Friday, August 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 27, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 15, 2015INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Tuesday, March 24, 2015PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, July 24, 2014CORRECTION UNDER SECTION 7 ¿ PROCESSED
Thursday, July 24, 2014ASSIGNED TO PARALEGAL
Wednesday, July 23, 2014LIMITATION FROM THE IB EXAMINED AND ENTERED
Friday, July 4, 2014LIMITATION OF GOODS RECEIVED FROM IB
Wednesday, April 30, 2014INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Tuesday, June 4, 2013PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, February 7, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, October 4, 2012CORRECTION UNDER SECTION 7 ¿ PROCESSED
Thursday, October 4, 2012ASSIGNED TO PARALEGAL
Thursday, October 4, 2012LIMITATION FROM THE IB EXAMINED AND ENTERED
Friday, September 28, 2012LIMITATION OF GOODS RECEIVED FROM IB
Wednesday, July 28, 2010FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 28, 2010FINAL DISPOSITION PROCESSED
Wednesday, July 28, 2010LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Wednesday, July 7, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 6, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, January 19, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 19, 2010PUBLISHED FOR OPPOSITION
Monday, December 14, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 11, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 11, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 11, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 11, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 11, 2009ASSIGNED TO LIE
Tuesday, November 24, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 6, 2009LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, September 29, 2009REFUSAL PROCESSED BY IB
Wednesday, September 23, 2009CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Friday, September 18, 2009CORRECTION TRANSACTION RECEIVED FROM IB
Friday, September 4, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 4, 2009REFUSAL PROCESSED BY MPU
Friday, September 4, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 3, 2009NON-FINAL ACTION WRITTEN
Thursday, August 27, 2009ASSIGNED TO EXAMINER
Tuesday, August 11, 2009APPLICATION FILING RECEIPT MAILED
Friday, August 7, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 6, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB